Anti-viral drug remdesivir has little to no effect on Covid patients' chances of survival, a study from the World Health Organization...
Drug manufacturer Gilead has questioned the findings, from a clinical study by the WHO.
Full Article
Anti-viral drug remdesivir has little to no effect on Covid patients' chances of survival, a study from the World Health Organization...
Upworthy
0 shares
1 views
You might like
Related news coverage
WHO and USFDA views on repurposed meds start a debate
Mid-Day
The World Health Organisation (WHO) and the US Food and Drug Administration (USFDA) have taken opposite stands on repurposed..
-
Group calls for end to 'cozy' and 'unacceptable' relationship between senior government officials and Facebook
National Post
-
Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors
-
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
Mid-Day
-
US stocks end mixed as investors weigh coronavirus stimulus package negotiations
Proactive Investors
Advertisement
More coverage
FDA Approves Remdesivir As A COVID-19 Treatment
Newsy
Watch VideoThe FDA has officially authorized remdesivir for the treatment of COVID-19, making it the first drug approved to treat..
-
US indices hit a snag as traders eye economic data and potential stimulus package agreement
Proactive Investors
-
US benchmarks start mixed as traders eye economic data and potential stimulus package agreement
Proactive Investors
-
US stocks set to start with gains after latest US presidential debate fails to spook investors, stimulus package hopes remain
Proactive Investors
-
US gives full approval for antiviral remdesivir drug to treat COVID-19 patients
Mid-Day